MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-13-2026
DarioHealth Corp. Total Non Current Liabilities 2011-2026 | DRIO
Annual Total Non Current Liabilities DarioHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.8 M | 30.2 M | 25.8 M | 19.8 M | 846 K | 222 K | 455 K | - | 1 K | 7.49 M | 2.61 M | 4 M | 2.7 M | 2.82 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.8 M | 1 K | 9.98 M |
Quarterly Total Non Current Liabilities DarioHealth Corp.
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.5 M | 33.5 M | 34.6 M | 22.7 M | 30.2 M | 32.6 M | 36.7 M | 41.1 M | 25.8 M | 30.4 M | 30.7 M | 18.4 M | 19.8 M | 25.9 M | 24.7 M | 48 K | 21 K | - | - | - | 222 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 41.1 M | 21 K | 24.4 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 17.26 | -7.0 % | $ 181 M |  China |
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
574 K | $ 1.34 | -17.79 % | $ 1.78 M |  USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 15.78 | -2.53 % | $ 477 M | USA |
 |
Agilent Technologies
A
|
3.29 B | $ 112.09 | -1.02 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 19.05 | 0.9 % | $ 552 M | USA |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
2.04 B | $ 139.97 | -2.28 % | $ 22.3 B | USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
10 M | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 19.83 | -3.22 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 94.74 | -2.0 % | $ 6.39 B | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 419.82 | 0.16 % | $ 12.1 B | USA |
 |
Mettler-Toledo International
MTD
|
1.61 B | $ 1 043.89 | 0.19 % | $ 21.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
107 M | $ 3.6 | -0.69 % | $ 333 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
NeoGenomics
NEO
|
435 M | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 18.46 | -2.48 % | $ 413 M | USA |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 157.18 | -1.33 % | $ 7.79 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
124 M | $ 186.22 | -5.43 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.45 B | $ 25.27 | -0.94 % | $ 24 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
91.4 M | $ 92.95 | -5.79 % | $ 11.7 B | USA |
 |
Senseonics Holdings
SENS
|
163 M | $ 5.73 | -1.55 % | $ 239 M | USA |
 |
Personalis
PSNL
|
639 K | $ 6.47 | -3.64 % | $ 577 M | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 117.95 | 0.73 % | $ 9.73 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
10.8 M | $ 52.99 | -0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
4.56 M | $ 49.3 | -6.89 % | $ 2.95 B | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 251.18 | -1.12 % | $ 20.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
22.5 B | $ 439.31 | -1.97 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
106 M | $ 0.57 | -1.49 % | $ 205 M | Irlanda |
 |
Celcuity
CELC
|
69.2 K | $ 134.9 | 0.13 % | $ 6.31 B | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
1.28 B | $ 331.34 | -0.56 % | $ 19.7 B | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 8.27 | -1.9 % | $ 1.79 B | USA |